Ellume recalls COVID tests over false positive concerns

BRISBANE: Brisbane testing biotech Ellume has recalled 2.2 million of its do-it-yourself coronavirus ... read more

Brainchip appoints new CEO but shares still drop

MELBOURNE: Brainchip investors do not appear impressed with the choice of its new ... read more

COVID testing lab expanding with NSW acquisition

MELBOURNE: Listed pathology provider Australian Clinical Labs (ACL) will double its market share ... read more

Mesoblast jumps higher after presentation on new drug

MELBOURNE: Stem cell treatments maker Mesoblast opened 10 per cent higher to $1.87 ... read more